All In MedTech

Device Trial Radar · NCT03795987

Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)

TNT/NW: Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)

Last checked: Nov 20, 2026Latest source record: Feb 26, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

15

Actual

Start

Feb 7, 2019

Primary completion

Aug 14, 2019

Study completion Aug 14, 2019

Sponsor

Lead sponsor
NightWareNot on our public-company list
Sponsor type
Industry
Collaborators
Minneapolis Veterans Affairs Medical Center
First posted
Jan 8, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with the NightWare digital therapeutic system. The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related nightmares and poor sleep quality.

Conditions

  • Stress Disorders, Post-Traumatic
  • Combat Disorders
  • Ptsd
  • Nightmare
  • Nightmares, REM-Sleep Type
  • Nightmare Disorder With Associated Non-Sleep Disorder

Interventions

  • NightWare Therapeutic SystemDevice

    A wearable digital therapeutic system that will measure physiologic data when worn during sleep to deliver a mild vibration via the watch to elicit arousal thereby disrupting nightmares. This detection and stimulation sequence will be performed according to NightWare's proprietary algorithm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in global score on the Pittsburgh Sleep Quality Index (PSQI) from Day 0 to Day 60Time frame: 0-60 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Minneapolis VA Healthcare System

    Minneapolis, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.